How to reduce DKA risk with SGLT2 inhibitors

THE risk of diabetic ketoacidosis (DKA) with sodium-glucose co-transporter-2 (SGLT2) inhibitors, flagged recently by the TGA, can be managed with careful supervision and monitoring, a specialist says.

# Tags